Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: A cohort study in 13 European centres
- 1 December 2005
- journal article
- Published by Wiley in Acta Paediatrica
- Vol. 94 (12), 1721-1731
- https://doi.org/10.1080/08035250500251999
Abstract
To determine the effectiveness of prenatal treatment for clinical manifestations of congenital toxoplasmosis.We prospectively identified 255 live-born infants with congenital toxoplasmosis using prenatal or neonatal screening. We determined the effect of prenatal treatment on the risks of intracranial or ocular lesions in infancy, accounting for gestational age at maternal seroconversion.Prenatal treatment within 4 wk of seroconversion reduced the risk of intracranial lesions compared with no treatment (odds ratio, OR 0.28; 95% CI: 0.08-0.75), but there was no significant effect when initiated after 4 wk (OR 0.76; 95% CI: 0.35-1.59; overall p-value 0.19). Compared to spiramycin alone, no treatment doubled the risk of intracranial lesions (OR 2.33; 95% CI: 1.04-5.50), but the risk did not differ with pyrimethamine-sulphonamide treatment (overall p-value 0.52). There was no consistent relationship between the type or timing of treatment and the risk of ocular lesions. Gestational age at maternal seroconversion was inversely associated with the risk of intracranial but not ocular lesions.Only early versus no prenatal treatment for intracranial lesions showed a statistically significant benefit. A large randomized controlled trial and/or meta-analysis of individual patient data from cohort studies is required to confirm these findings.Keywords
This publication has 23 references indexed in Scilit:
- Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birthBJOG: An International Journal of Obstetrics and Gynaecology, 2004
- Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondiiBJOG: An International Journal of Obstetrics and Gynaecology, 2003
- Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosisInternational Journal of Epidemiology, 2001
- Toxoplasma gondii in Primary Rat CNS Cells: Differential Contribution of Neurons, Astrocytes, and Microglial Cells for the Intracerebral Development and Stage DifferentiationExperimental Parasitology, 1999
- Treatment of toxoplasmosis during pregnancy: A multicenter study of impact on fetal transmission and children’s sequelae at age 1 yearAmerican Journal of Obstetrics and Gynecology, 1999
- Regulation and Function of T-Cell-Mediated Immunity duringToxoplasma gondiiInfectionClinical Microbiology Reviews, 1998
- Letter to the EditorBritish Journal of Clinical Pharmacology, 1998
- Termination of pregnancy for maternal toxoplasmosisThe Lancet, 1994
- Neonatal Serologic Screening and Early Treatment for Congenital Toxoplasma gondii InfectionNew England Journal of Medicine, 1994
- In utero Treatment of Toxoplasmic Fetopathy with the Combination Pyrimethamine-SulfadiazineFetal Diagnosis and Therapy, 1993